Showing results (91-100 of 541) with videos related to
Sort By:
Pageof 55
Drugs - Real World Outcomes|March 14, 2025
Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World CohortTommaso Guerra, Francesca Caputo, Antonella Bianco, et al.Drugs - Real World Outcomes|October 29, 2024
Comparison of the Safety of Aspirin Monotherapy and Aspirin and P2Y12 Inhibitor Combination Therapy in Patients Post Coil Embolization During Admission: A Cross-Sectional Study Using a Nationwide Inpatient DatabaseHiroshi Magara, Yuri Nakamura, Takuaki Tani, et al.Drugs - Real World Outcomes|August 1, 2024
Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection FractionFreny Vaghaiwalla Mody, Ravi K Goyal, Mayank Ajmera, et al.Drugs - Real World Outcomes|June 24, 2024
Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis RegistryMark Lebwohl, Bruce Strober, Amy Schrader, et al.Drugs - Real World Outcomes|July 22, 2024
Impact of Third-Generation Antiseizure Medications on People with Epilepsy in a Low-Income Population: The Brivaracetam Experience in a Real-World StudyCamilo Espinosa-Jovel, Natalia Valencia, Lisa Gaitán, et al.Drugs - Real World Outcomes|June 9, 2024
Association of Drug-Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-AnalysisJoshua M Inglis, Gillian Caughey, Tilenka Thynne, et al.Drugs - Real World Outcomes|November 15, 2023
Clinical Characteristics and Treatment of Irritable Bowel Syndrome in a Colombian Population: A Cross-Sectional StudyDaniel Andrés Hernández-Velásquez, Esteban Rodríguez-Martínez, Jhonathan David Montoya-Meneses, et al.Drugs - Real World Outcomes|April 2, 2024
Ceftaroline Fosamil for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Real-World Comparative Clinical Outcomes StudyJennifer Hammond, Michael Benigno, Nataly Bleibdrey, et al.Drugs - Real World Outcomes|March 31, 2024
Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System DatabaseYuichi Uwai, Tomohiro NabekuraDrugs - Real World Outcomes|January 24, 2024
Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from EnglandJanet Brown, Brooke Harrow, Anne Marciniak, et al.Pageof 55